The publisher regrets that the affiliations for the authors in this article were incorrect at the time the article was published. They are correct as presented within this erratum.
The publisher would like to apologise for any inconvenience caused.
. 2022 Mar 17;7(2):100460. doi: 10.1016/j.esmoop.2022.100460
Erratum to ‘Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients’
[ESMO Open Volume 7, Issue 1, February 2022, 100393]
R Beechinor
1,2,∗, A Palumbo
3, HK Chew
1,4, M Arora
1,4
R Beechinor
1UC Davis Comprehensive Cancer Center, Sacramento
2University of California, San Francisco School of Pharmacy, San Francisco
Find articles by R Beechinor
A Palumbo
3Department of Pharmacy, Oregon Health and Science University, Portland
Find articles by A Palumbo
HK Chew
1UC Davis Comprehensive Cancer Center, Sacramento
4Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, USA
Find articles by HK Chew
M Arora
1UC Davis Comprehensive Cancer Center, Sacramento
4Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, USA
Find articles by M Arora
1UC Davis Comprehensive Cancer Center, Sacramento
2University of California, San Francisco School of Pharmacy, San Francisco
3Department of Pharmacy, Oregon Health and Science University, Portland
4Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, USA
∗
Correspondence to: R. Beechinor RBeechinor@ucdavis.edu
Collection date 2022 Apr.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
PMCID: PMC8933809 PMID: 35306439